2.1
Galcanezumab (Emgality, Eli Lilly) is 'indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month'.
2 Information about galcanezumab
Marketing authorisation indication
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics.
Price
2.3
The list price of galcanezumab is £450.00 per 120‑mg injection (excluding VAT; Monthly Index of Medical Specialities online, accessed October 2020). The company has a commercial arrangement. This makes galcanezumab available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.